Cadence Sues Exela, Paddock To Block Generic Ofirmev
Cadence Pharmaceuticals Inc. launched a patent infringement suit against generics makers Paddock Laboratories Inc. and Exela Pharma Sciences LLC in Delaware federal court on Thursday, seeking to block a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article